Along with Prevas Aerocrine has developed two innovations that have improved the care of asthma patients - NIOX ® and NIOX MINO ®.
Assignment: System and Project delivery, outsourced development department.
Aerocrine is a world leading company in the field of monitoring airway inflammation.
The challenge presented to Prevas was to create a small easy to use hand held device producing accurate and reproducible results in line with the much more technically complex NIOX®.
Prevas used its full spectrum of engineering talents to develop a new innovative concept that permitted the miniaturization of the device as well as the reduction in manufacturing cost. The result was NIOX MINO®. The project was delivered as an out-sourced development department.
NIOX MINO® is the first and only hand held NO analyzer on the market. Several patents was generated during the project. In 2005, NIOX MINO® was awarded with the Medical Design Excellence award (MDEA).
Do you want to know more about this project or find out what Prevas can do for you, please contact us.
Anders Eklund, e-mail